Overview

Phase II Study of Gemcitabine and TS-1 in Biliary Trat Cancer

Status:
Terminated
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
In current study, we evaluate the efficacy of gemcitabine and TS-1 combination chemotherapy in advanced BTC.
Phase:
Phase 2
Details
Lead Sponsor:
Samsung Medical Center
Treatments:
Gemcitabine